$PHARMA - The unprecedented scale of COVID-19 clinical trials suggests a positive outlook for pharmaceutical companies involved in treatment research.
$BIOTECH - The accelerated timeline for vaccine development, despite still taking considerable time, suggests a positive outlook for biotech companies involved in vaccine research.
$HC - The emphasis on extensive testing, particularly for frontline workers, as part of safely reopening the economy suggests increased demand and growth in the healthcare sector.
$TECH - The need for improved testing technology to facilitate reopening suggests a positive outlook for companies in the technology sector, particularly those involved in developing rapid and accurate testing methods.
Bearish:
$HOSP - Public reluctance to engage in activities that could risk health, even without official orders, suggests continued challenges for the hospitality sector.